Clinical Trials Directory

Trials / Completed

CompletedNCT07278024

Postbiotic Intervention on Vaginal Microbiota

To Investigate the Effect of Postbiotic Intervention on Vaginal Microbiota in Infertile Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Kaohsiung Veterans General Hospital. · Academic / Other
Sex
Female
Age
30 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study investigates the effects of postbiotic intervention on vaginal microbiota in infertile patients. Using a pre-post test design, we will enroll 15 women aged 30-45 years with at least two IVF failures. Participants will receive postbiotic intervention for 8 weeks. Vaginal secretion samples will be collected before and after treatment for 16S rRNA sequencing analysis to assess microbial composition, dominant species distribution, α-diversity index, and Lactobacillus content. Primary outcomes include changes in vaginal microbiota composition and diversity, alterations in Lactobacillus abundance, and pregnancy rates in subsequent IVF-FET cycles.

Detailed description

Background The demand for infertility treatment is increasing, with approximately 10-15% of couples of reproductive age experiencing varying degrees of fertility issues. Vaginal microbiota dysbiosis may be a significant factor contributing to infertility, and a healthy vaginal microbiota environment plays a crucial role in embryo implantation. This study aims to investigate the effects of postbiotic intervention on the vaginal microbiota of infertile patients by analyzing the vaginal microbiota before and after bacteriocin treatment to evaluate its effectiveness in improving the vaginal microbial environment. Objective This study aims to investigate changes in vaginal microbiota before and after the use of postbiotic intervention. Methods This study employs a pre-post test design, planning to enroll 15 women aged 30-45 years diagnosed with infertility with at least two IVF treatment failure. All subjects must be free from severe gynecological diseases, not using antibiotics or probiotics, and without acute vaginal infection symptoms. The study period is 8 weeks. Before intervention, baseline data collection will include complete medical history and infertility treatment records. During the first visit, vaginal secretion samples will be collected for vaginal microbiota assessment through 16S rRNA sequencing analysis, simultaneously measuring Lactobacillus content and microbial diversity. Subjects will then use postbiotic intervention continuously for 8 weeks. After treatment, a second sampling will be conducted to re-analyze the vaginal microbiota. The primary outcome measures include changes in microbial composition before and after use, including dominant species distribution, α-diversity index, and changes in Lactobacillus content. All specimens will be collected, transported, and preserved following standard operating procedures to ensure testing quality. Research data will be analyzed using paired sample statistical methods to assess pre-post treatment differences, with significance level set at p\<0.05. Outcome 1. Compare differences in vaginal microbiota before and after using postbiotic intervention. 2. Compare differences in taxonomic abundance before and after using postbiotic intervention. 3. Check pregnancy rate of IVF-FET cycle after postbiotic intervention use

Conditions

Interventions

TypeNameDescription
OTHERpostbioticsParticipants will self-administer postbiotic intervention via intravaginal suppositories containing purified bacteriocin peptides . The intervention consists of one suppository administered intravaginally at bedtime, once daily for 8 consecutive weeks (56 days total). Each suppository contains a standardized concentration of bacteriocins extracted from Lactobacillus strains.

Timeline

Start date
2025-04-01
Primary completion
2025-07-31
Completion
2025-11-30
First posted
2025-12-11
Last updated
2025-12-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07278024. Inclusion in this directory is not an endorsement.